XML 39 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Collaboration and License Agreements (Tables)
 9 Months Ended
Sep. 30, 2017
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Summary of Revenue from Collaboration and License Agreements

We have recognized revenue from our collaboration and license agreements as follows (in thousands):  

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

BMS and Pfizer

 

$

1,038

 

 

$

1,798

 

 

$

3,824

 

 

$

4,785

 

Daiichi Sankyo

 

 

2,034

 

 

 

3,810

 

 

 

6,227

 

 

 

8,491

 

Bayer and Janssen

 

 

544

 

 

 

3,316

 

 

 

1,880

 

 

 

7,431

 

Bayer

 

 

212

 

 

 

398

 

 

 

812

 

 

 

1,052

 

Other

 

 

—

 

 

 

—

 

 

 

—

 

 

 

52

 

Total collaboration and license revenue

 

$

3,828

 

 

$

9,322

 

 

$

12,743

 

 

$

21,811